Filing Flows › Innoviva (INVA) › R&D spending
Innoviva (INVA) R&D spending by quarter
Innoviva's R&D spending was $5.2M in Q3 2026 (third quarter 2026), +0.5% from Q2 2026. Over the last 7 quarters it ranged from $4.4M (Q1 2025) to $13.7M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.2M | +0.5% | -62% |
| Q2 2026 | $5.2M | -1% | -35% |
| Q1 2026 | $5.2M | +15% | +19% |
| Q4 2025 | $4.6M | -67% | — |
| Q3 2025 | $13.7M | +71% | — |
| Q2 2025 | $8.0M | +82% | — |
| Q1 2025 | $4.4M | — | — |
Q3 2026 at a glance
Innoviva, Q3 2026: revenue $106M (-2% year over year), operating margin 39.7%, net loss $73.9M, operating cash flow $41.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innoviva's R&D spending?
Innoviva's R&D spending was $5.2M in Q3 2026 (third quarter 2026), +0.5% from Q2 2026.
How has Innoviva's R&D spending changed?
Over the last 7 quarters it ranged from $4.4M (Q1 2025) to $13.7M (Q3 2025).